Skip to main content
. Author manuscript; available in PMC: 2008 Jul 2.
Published in final edited form as: Drug Metab Dispos. 2007 Mar 7;35(6):973–980. doi: 10.1124/dmd.107.014779

Fig. 7.

Fig. 7

Three-dimensional model of the active site of polymorphic human CBR1 V88I with the substrate PGE2. In this view, the polymorphic V88I residue is located behind the NADP molecule (pink). The catalytic residues Y194, K198, and S140 are shown in light blue, and PGE2 is shown in yellow. Other side chains are shown in thin lines.